Navigation Links
Boffins Identify Molecule That Might Treat Food Allergy

Boffins have identified a key molecule Interleukin-12 (IL-12),that may provide resistance against food allergy.

During a food allergy the immune system responds to a food protein as if it was harmful. The immune system produces immunoglobulin E (IgE) antibodies, which normally help the body fight parasites. In the most severe cases individuals can suffer life-threatening reactions, including anaphylactic shock.

The study was conducted by a team of researchers led by Dr Claudio Nicoletti at the Institute of Food Research in Norwich, in collaboration with the University of Siena.

Earlier studies have shown that special types of white blood cells called dendritic cells help the immune system to decide on how to respond to foreign molecules.

As part of this study, researchers compared the activity of dendritic cells in the gut and in the spleen of allergic and allergy resistant mice.

Researchers found that the dendritic cells stopped producing IL-12 in the gut of susceptible mice.

"We have identified a molecule that is very important for the regulation of immune response and for the first time clearly represents a potential target for the therapy of allergy. This is currently under investigation", Dr Nicoletti said.

The findings of the study were published online in the July issue of the Journal of Allergy and Clinical Immunology.


'"/>




Page: 1

Related medicine news :

1. Fizzy Logic For A Perfect Drink: Courtesy Boffins
2. Boffins Identify Fifth Gene Behind Joubert Syndrome
3. Boffins Find Link Between Common Sleep Disorder and Hypertension
4. Boffins a Step Closer to Solving Puzzle of Lou Gehrigs Disease
5. Boffins Identify Gene That Helps Regulates Body Weight
6. Boffins Link Atkins Diet With Bowel Cancer
7. Boffins Develop New Technique to Hunt Illness-causing Mutants in Non-gene DNA
8. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
9. Identifying bacteria made amiable
10. Identifying brain lesions with impaired consciousness
11. Identifying Virus Found To Be Essential for HIV Patients
Post Your Comments:
(Date:5/9/2008)...IGNA HealthCare of Arizona and Catholic,Healthcare...ely, CIGNA plan,members will have in-network acces...althcare West facilities and providers. The contra... hospitals, including St. Joseph,s,Hospital and Me...rcy,Gilbert Medical Center, and affiliated facilit...
(Date:5/9/2008)...re-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFA...rsing,services, today announced that the underwrit...llotment option in part and purchased 262,500,addi...ng price of $17.75,per share. Including the over-a... offering for net proceeds of $41.8 million, after...
(Date:5/9/2008)... those who take up the habit , , FRIDAY,...udents to spread anti-smoking messages in their ev...ng rates, according to a U.K. study. , The s...3, at 59 schools in western England and Wales. At ...to receive training about the risks of smoking, th...
(Date:5/9/2008)...ma, depression and many other diseases, researcher... -- A new class of drugs called vaptans may be abl...painful periods, brain hemorrhage, psychotic disor..., Vaptans, short for vasopressin-receptor antagoni...tem, which plays an important role in controlling ...
Breaking Medicine News(10 mins):Health News:CIGNA HealthCare of Arizona and Catholic Healthcare West Reach Agreement 2Health News:Almost Family, Inc. Announces Exercise of Over-Allotment Option 2Health News:Training Student Leaders Cuts Peers' Smoking Rates 2Health News:New Class of Drugs Might Treat Many Conditions 2
...on has come a long way. The number of successfully...nd more people lead a normal lifestyle. //However,...tters when matching donor and recipient kidneys,” ...w perspective but also the transplant community. ...
...have poor functioning of a key heart measure may b... arteries.// The researchers looked specifically a...vessels in the arteries, called endothelial functi... blockage, or atherosclerosis. More than 2,000 peo...
... of disability and death in Western countries. Bec...remains the best approach. Obesity in middle-aged ...doubling its likelihood later in life, according t...eden between ages 47 and 55 were followed for 28 y...
...ons, known as chronic rhinosinusitis, do not appea...// long periods of time, shows new research. Rese... of antibiotics as a first-line treatment for chro...onsidered. However, they say little data exist on ...
Other Medicine News:
(Date:5/8/2008)...ormulation May Provide New Option for Clinicians C...n Using an Oral NSAID, TAMPA, Fla., May 8 /PRNews...leading global specialty pharmaceutical company, a...is week at the American Pain Society annual,meetin...ive pharmacokinetic,profile of Alpharma Pharmaceut...
(Date:5/7/2008)...ional Study to Evaluate Efficacy and Safety in Tre... Blindness, LEVERKUSEN, Germany, MONTVILLE, New J...irstCall/ -- Bayer HealthCare AG and Regeneron,Pha...d that the first patient,has been dosed in the VIE...velopment program evaluating VEGF Trap-Eye for the...
(Date:5/7/2008)...IEGO, May 7 /- Arena Pharma...hat Taisho Pharmaceutical Co., Ltd.,initiated a Ph...PCR-focused,partnership with Arena to develop comp...didate is a novel oral compound intended for the t...re very happy to see our long-standing partner, Ta...
(Date:5/7/2008)... study shows how sounds are amplified in the inner...s can result from genetic mutation or,overdose of ...wire/ -- St. Jude Children,s,Research Hospital inv...,amplification mechanism in the cochlea of the ear...her mammals. The findings will enable better,under...
Breaking Medicine Technology:Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 2Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 3Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 4Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 5Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 6Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 7Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 2Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 3Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 4Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 5Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 6Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd. 2Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd. 3St. Jude Finds 'Dancing' Hair Cells Are Key to Humans' Acute Hearing 2St. Jude Finds 'Dancing' Hair Cells Are Key to Humans' Acute Hearing 3Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 136 1Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 136 2Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 136 3Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 136 4Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 136 5Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 136 6Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 136 7Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products 184 1Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products 184 2Smoking increases risks for head and neck cancers for men and women 189 1When is a stem cell not really a stem cell 3F 151 1When is a stem cell not really a stem cell 3F 151 2
...udy of over 7,700 women published today shows redu...ent in hip fractures, EAST HANOVER, N.J., May 02, ...clast(R) (zoledronic acid) Injection significantly...c bone fractures,over three years in women with po...oday in The New England Journal of Medicine,marks...
...TON, May 03, 2007 /PRNewswire/ -- Bayer HealthCare...ree clinical,studies with Betaseron(R) (interferon...demy of Neurology,s (AAN) 59th Annual Meeting,dem... and high,patient satisfaction with treatment in p... (MS). , "Collectively, these studies highlight th...
Other Medicine Technology:Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 2Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 3Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 4Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 5Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 6Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 3Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 4
... portability & capability together in this user-fr...e & desktop maginifcation., ,With its battery ...magnification device will meet any individual, edu...,Carry it like a briefcase from room to room or ...
...etter. Introducing Disposable Bimanuals. With the...the need for quality single-use bimanuals. Oasis m...disposable bimanuals. Single use bimanuals decreas...y encompass all the advantages of bimanual MICS in...
...can have accurate patient information and secure d...Keep track of patient schedules, manage daily work... PC handheld device. PhysAssist IQ is a handheld P...es not require physicians to change the way they d...
...F40 with its new stand F19 contains three high pre...he one hand to homogenously move the arms and on t...icroscope. The Leica M844 F19 carries the original...footprint and holds the same Two-in-One display an...
Medicine Products: